| pubmed-article:12891190 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C1522564 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0190211 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:12891190 | lifeskim:mentions | umls-concept:C2699007 | lld:lifeskim |
| pubmed-article:12891190 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12891190 | pubmed:dateCreated | 2003-7-31 | lld:pubmed |
| pubmed-article:12891190 | pubmed:abstractText | Randomized trials have indicated that primary coronary angioplasty performed in patients admitted directly to highly-experienced angioplasty centers offers certain advantages over intravenous fibrinolytic therapy. However, the large majority of patients with acute myocardial infarction are submitted to hospitals without a catheterization laboratory. This means that additional transportation will be necessary for many patients if a strategy of acute coronary angioplasty is to be introduced as routine treatment. The delay of treatment caused by transportation might negate (part of) the benefits of primary angioplasty compared to fibrinolytic therapy given immediately at the local hospital. | lld:pubmed |
| pubmed-article:12891190 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12891190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891190 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12891190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891190 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12891190 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12891190 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:NielsenTorste... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:GrandePeerP | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:AndersenHenni... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:ThayssenPerP | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:VesterlundTho... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:AbildgaardUlr... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:PedersenFlemm... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:MortensenLeif... | lld:pubmed |
| pubmed-article:12891190 | pubmed:author | pubmed-author:DANAMI-2... | lld:pubmed |
| pubmed-article:12891190 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12891190 | pubmed:volume | 146 | lld:pubmed |
| pubmed-article:12891190 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12891190 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12891190 | pubmed:pagination | 234-41 | lld:pubmed |
| pubmed-article:12891190 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:meshHeading | pubmed-meshheading:12891190... | lld:pubmed |
| pubmed-article:12891190 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12891190 | pubmed:articleTitle | Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). | lld:pubmed |
| pubmed-article:12891190 | pubmed:affiliation | Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark. henning.rud.andersen@iekf.au.dk | lld:pubmed |
| pubmed-article:12891190 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12891190 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12891190 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12891190 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12891190 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891190 | lld:pubmed |
